Integrated Care News by CFHA
MAY 19, 2025
Rather, it is an evidence-based, collaborative process that mirrors the well-established framework of using physical symptom monitoring (e.g., vital signs, bloodwork laboratory findings, and other physical test data) as a means of guiding care over time. MBC is much more than simply administering behavioral health measures.
Family Physicians of St. Joseph
SEPTEMBER 25, 2018
In 2007, Dr. Mancini joined the practice, followed by Dr. Meadows in 2012, and Dr. Gendernalik in 2015. they provide free sports physicals for youth in Berrien Springs and New Buffalo. Larger companies now dominate the healthcare landscape, yet through innovation and a dedication to exceptional patient care, Family Physicians of St.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 19, 2025
Gowin and his colleagues analyzed data from 1,003 adults between 22 and 36 years of age who had functional magnetic resonance imaging (fMRI), urine toxicology, and cannabis use results collected at one academic site between 2012 and 2015 as part of the Human Connectome Project. The cohort (mean age, 28.7
FDA Law Blog
NOVEMBER 1, 2023
In fact, stakeholders have repeatedly challenged FDA’s assertions of authority in Citizen Petitions, public comments, and other forums. Premarket Approval or De Novo pathways).
Doctor On Demand
APRIL 16, 2025
The American Thoracic Society’s 2015 study, “The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis,” found that clearing excess mucus is a significant factor in protecting the lungs from “inhaled infectious and noninfectious challenges.”
33 Charts
OCTOBER 2, 2021
It’s the physics of physician bandwidth: You can’t add something without taking something away. This thread from a 2015 post illustrates how varying needs of a child with ulcerative colitis call for different ways to connect: Take Luke, a school-aged child with moderate ulcerative colitis complicated by sclerosing cholangitis.
FDA Law Blog
FEBRUARY 29, 2024
A surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit. The use of a surrogate endpoint can considerably shorten the time required prior to receiving FDA approval. FDA-2022-E-3124 ).
Expert insights. Personalized for you.
100 
Let's personalize your content